Key result
Diabetes combined with acute coronary syndrome was associated with the lowest 1-year survival (90%) compared to non-diabetics without ACS (96%) following PCI with drug-eluting stents (P=0.03).
Why the study?
Does the combination of diabetes and acute coronary syndrome reduce 1-year survival in patients treated with drug-eluting stents?
Population
887 consecutive patients who underwent percutaneous coronary intervention with drug-eluting stents at UCLA…
Comparison
Presence of diabetes and acute coronary syndrome vs Patients with no diabetes and no ACS, no…
Design
Cohort
Follow-up
1 year
Authors
Loading...
May warrant closer post-PCI surveillance in diabetic ACS patients; leaves open whether targeted strategies improve survival.
Cohort (n=887)
No
Does the combination of diabetes and acute coronary syndrome reduce 1-year survival in patients treated with drug-eluting stents?
Absolute Event Rate: 90% vs 96%
p-value: p=0.03
In the drug-eluting stent era, patients with both diabetes and acute coronary syndrome face a significantly higher risk of 1-year mortality compared to those with only one or neither condition.
Lee et al. (2008) conducted a cohort in Patients undergoing percutaneous coronary intervention with drug-eluting stents (n=887). Diabetes and acute coronary syndrome vs. No diabetes and no acute coronary syndrome was evaluated on Survival at 1 year (p=0.03). Diabetes combined with acute coronary syndrome was associated with the lowest 1-year survival (90%) compared to non-diabetics without ACS (96%) following PCI with drug-eluting stents (P=0.03).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: